Study Objectives: Neuroligin-3 (NLGN3) is one of the many genes associated with autism spectrum disorder (ASD). Sleep dysfunction is highly prevalent in ASD, but has not been rigorously examined in ASD models. Here, we evaluated sleep/wake physiology and behavioral phenotypes of rats with genetic ablation of Nlgn3. Methods: Male Nlgn3 knockout (KO) and wild-type (WT) rats were assessed using a test battery for ASD-related behaviors and also implanted with telemeters to record the electroencephalogram (EEG), electromyogram, body temperature, and locomotor activity. 24-h EEG recordings were analyzed for sleep/wake states and spectral composition. Results: Nlgn3 KO rats were hyperactive, exhibited excessive chewing behavior, and had impaired prepulse inhibition to an auditory startle stimulus. KO rats also spent less time in non-rapid eye movement (NREM) sleep, more time in rapid eye movement (REM) sleep, exhibited elevated theta power (4-9 Hz) during wakefulness and REM, and elevated delta power (0.5-4 Hz) during NREM. Beta (12-30 Hz) power and gamma (30-50 Hz) power were suppressed across all vigilance states.
INTRODUCTION
Autism spectrum disorder (ASD) is characterized by social deficits, perseverative behaviors, and/or restricted interests. Although the cause(s) of ASD are not fully understood, it is generally thought that both genetic and environmental factors play a role. Gene association studies have identified a number of genes that either cause or contribute to ASD, one of which is NLGN3, a gene that encodes a postsynaptic protein important for synaptic maturation and transmission. [1] [2] [3] Five members of the Nlgn family have been identified to date; these cell adhesion molecules interact with presynaptic neurexins 4 to regulate synaptic strength at GABAergic and glutamatergic synapses, thereby influencing excitatory/inhibitory (E/I) balance in the central nervous system (CNS). [5] [6] [7] [8] Nlgn-3 is widely distributed in the cortex, hippocampus, thalamus, and cerebellum. 2 Expression of Nlgn-1 and Nlgn-2 in non-neuronal cells induces development of presynaptic structures and synaptic vesicles in neighboring axons 9 , whereas knockdown of neuroligins causes a reduction in dendritic spine density, 10 suggesting a role for neuroligins in synaptic formation as well as maturation. Mice with the Nlgn3 R451C mutation exhibit enhanced inhibitory transmission, with elevated levels of the vesicular GABA transporter in the hippocampus and cortex and higher frequencies of spontaneous inhibitory postsynaptic currents in the somatosensory cortex. 11 The use of animal models is crucial for both understanding the pathogenesis of neurological disorders and in the development of novel therapies for these disorders. A number of models have been proposed for investigation of ASD including mouse and rat strains with various Nlgn3 mutations. 11, 12 These models exhibit construct validity as well as behavioral phenotypes analogous in nature to the core features that characterize ASD. However, ASD is widely recognized as a heterogeneous disorder with a complex behavioral profile encompassing many secondary behavioral phenotypes. Therefore, in order to fully capture the complexity of ASD in an animal model, it is important to study both core and non-core phenotypes.
Sleep dysfunction is common to many neurological disorders including ASD in which the incidence of sleep problems has been reported to range from 78 to 88%. 13 Sleep disturbances most often reported in ASD include increased latency to sleep, increased night awakenings, decreased non-rapid eye movement (NREM) sleep and sleep spindles, and decreased rapid eye movement (REM) sleep. 14, 15 Changes in the spectral composition of the different stages of wake/sleep have also been reported, including elevated theta power during wakefulness in the evening and reduced beta power during REM sleep. 16 Other studies suggest elevated levels of delta and theta power and lower levels of alpha during rest. 17 Sleep problems often affect cognitive function which can potentially exacerbate other ASD symptoms. 18 To date, there have been few studies in which sleep has been evaluated in ASD rodent models. [19] [20] [21] [22] However, studies across multiple species reveal wake/sleep physiology abnormalities in ASD-related models and various models in the neurexin or neuroligin family. Rats exposed to valproic acid exhibit more time awake and less time in NREM sleep. 19 Cntnap2 knockout (KO) rats have increased consolidation of wakefulness and REM sleep, whereas wakefulness in KO mice is fragmented.
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Nlgn1 KO mice spend more time in NREM sleep 23 , and mutations in the Drosophila neurexin-1 and neuroligin-4 result in sleep fragmentation. 24, 25 Although the duration and distribution of sleep and wakefulness did not differ between Nlgn3 R451C knock-in (KI) and control mice, the electroencephalographic (EEG) power spectral profiles were significantly altered during both wake and sleep. 26 Since wake/sleep defects have been identified in ASD models and in animal models with mutations in either the neurexin or neuroligin family, we hypothesized that disruption of Nlgn3 would similarly cause abnormalities in behavior and wake/sleep physiology in the newly developed Nlgn3 KO rats.
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METHODS
Animals
Male Nlgn3 KO and wild-type (WT) rats (n = 10/genotype) were generated as previously described 12 on a Sprague Dawley background (SD-Nlgn3
tm1sage
) and obtained from Horizon Discovery (Boyertown, PA). Due to the breeding scheme used by Horizon, the WT rats were not littermates of the KO animals, although the WT animals originated from the same line used to breed the KO rats. The KO rats were sixth generation, born from a KO female × KO male. The grandparents were heterozygous (HT) female × KO male, and the great-grandparents were HT females × WT Sprague Dawley males. All breeding cages used to generate both WT and KO rats were housed in the same room and located on the same rack. At SRI International, all animals were housed in ventilated, light-tight chambers on a 12:12 h light:dark cycle, maintained at 22 ± 2°C with 50 ± 20% relative humidity. Animals were provided water and food ad libitum and were initially group-housed, but single-housed following surgery. Daily monitoring of animal health was performed in accordance with Association for Assessment and Accreditation of Laboratory Animal Care and SRI guidelines. Experiments were approved by the SRI International Institutional Animal Care and Use Committee (IACUC) in accordance with NIH guidelines for the care and use of laboratory animals.
Behavior
Behavioral experiments began at ~6 weeks of age ( Figure 1 ). Rats were evaluated through a sequence of tests, each separated by at least one day. Animals were acclimated to the test room for at least 30 min prior to testing. All experiments were performed during the light phase (between Zeitgeber Time (ZT) 3-7). All behavior scoring was performed blind to genotype.
Open-Field Activity Assay
Exploratory activity in a novel environment 27 was tested by placing rats individually in a black acrylic open-field arena (43 × 43 × 30 cm; Med Associates Inc., St. Albans City, VT). A video camera mounted directly above the arena captured movement and was subsequently analyzed with video tracking software (EthoVision, Noldus Information Technology, Wageningen, the Netherlands). The light intensity during the test was 50 lux. Total distance traveled (cm) during a 20-min exploration period was quantified.
Social Interaction
Social behavior was evaluated using a social interaction test. 28, 29 Rats were single-housed overnight and paired the following day with weight-matched unfamiliar animals of the same genotype. Each pair was placed in a clean standard housing cage (45.5 × 23.5 × 21 cm) with a clear cage lid. An overhead camera recorded behaviors for 10 minutes. Social behaviors (i.e., a subject initiated a social interaction with the partner including sniffing, following, and grooming) and play behaviors (pinning, pouncing, wrestling, chasing, and play grooming) were scored using EthoVision (Noldus Information Technology, Wageningen, the Netherlands).
Sociability
Preference for a live social stimulus was ascertained with a sociability test. 30 The apparatus used was a clear acrylic box (90 × 40 × 30 cm) with three equally sized chambers (30 × 40 × 30 cm), each connected by a vertical opening (9 cm wide). The two end compartments also contained a clear partition with holes in order to physically isolate the test subject from the social/ non-social stimuli while allowing for olfactory stimuli to pass through. Subjects were habituated to the empty test box for 10 minutes after which the subject was removed, and an unfamiliar, age-matched rat of the opposite genotype was placed in one of the two end compartments to serve as the "social" stimulus. A stuffed rat toy of similar color, size, and shape was placed in the opposite end compartment as the "nonsocial" stimulus. Subjects were placed in the middle of the box and video-recorded with an overhead camera for 10 minutes. Videos were scored for frequency and duration of time spent in each chamber and at each partition (social vs. nonsocial stimulus) using EthoVision (Noldus Information Technology, Wageningen, the Netherlands).
Light-Dark Exploration
Anxiety-related behaviors were measured using the light-dark box test 31 by placing a rat in a black acrylic open-field arena (43 x 43 x 30 cm; Med Associates Inc., St. Albans City, VT) containing a black acrylic insert that divided the arena into two equally sized chambers separated by a small opening (11.5 cm × 9 cm). One chamber was illuminated (50 lux) with an open top, whereas the second chamber was black with a closed top. Each animal was placed on the illuminated side, and transitions between the chambers were measured during a 10-min test. A transition was tallied once all four paws of the subject completely transferred from one chamber to the next.
Chew Behavior
In order to gauge repetitive behaviors, 12, 28 chew behavior was assessed at 26 weeks of age by providing single-housed rats a pre-weighed Apple Stick (Kaytee Products, Inc., Chilton, WI). Each Apple Stick was weighed after an ~16-h exposure, and the percentage of wood chewed was calculated.
Startle Response and Prepulse Inhibition
Sensorimotor gating and startle responses 32 were studied at 25 weeks of age using the SR-LAB startle response system (San Diego Instruments, San Diego, CA) as previously described. 33, 34 Rats were placed in clear, cylindrical holding tubes within a sound attenuating chamber and habituated to white noise (70 dB) for 5 minutes. Subjects were then acclimated to the startle stimulus using six startle-only presentations (120 dB and 40 ms). The test was comprised of six blocks, each including the following eight trial types presented in a pseudo-randomized order: no stimulus (70 dB), startle stimulus (120 dB and 40 ms), three prepulse only stimuli (74, 78, and 82 dB; 20 ms), and three trials in which the prepulse stimulus was presented 100 ms before the startle stimulus (e.g., 74 dB prepulse + 120 dB startle). The intertrial interval was 10-20 s. Startle responses were detected as a force change within the holding tube and were recorded for 65 ms following stimulus presentation. Percent inhibition of the startle response was calculated for each prepulse as follows: 100 − [(response to trials with prepulse and startle stimulus/response to trials with startle stimulus alone) × 100]. The final score was the average percentage prepulse inhibition (PPI) across all three prepulses. Surgery Rats (9 weeks of age, body weight range = 263-413 g) were surgically implanted with F40-EET biotelemetry transmitters (Data Sciences International, St. Paul, MN) for recording the EEG, the electromyogram (EMG), locomotor activity (LMA), and core body temperature (T b ) as previously described. [35] [36] [37] Animals were maintained under anesthesia with ~2-3% isoflurane. Transmitters were implanted in the abdomen and the wires were subcutaneously channeled to the head. EMG leads were bilaterally inserted within the nuchal muscles and sutured in place using non-absorbable suture. Bilateral cranial holes were made for EEG leads (2 mm anterior to bregma, 2 mm lateral to the midline and 5 mm posterior to bregma, 3 mm lateral to the midline) which were fixed to the skull with dental acrylic. Animals were provided subcutaneous saline and buprenorphine as a postoperative analgesic and were closely monitored for 14 days at which point all sutures were removed. Animals were single-housed, provided at least 2 sources of environmental enrichment in accordance with SRI IACUC guidelines (e.g., paper towel, nestlet, and PVC/ polycarbonate house/tunnel), and allowed at least 2 weeks for recovery before recording. One WT and one KO rat were not useable due to faulty transmitters and were euthanized before EEG studies began; consequently, we conducted EEG/EMG recordings from nine rats of each genotype.
Electrophysiological Data Acquisition
Data were collected using DataQuest ART (Data Sciences International, St. Paul, MN). EEG and EMG were sampled at 500 Hz with filter cutoffs at 200 Hz (EEG) and 100 Hz (EMG). LMA and T b measurements were recorded in 10-s increments. Except for the sleep deprivation (SDep) and rodent multiple sleep latency test (rMSLT) 38 experiments, recordings were conducted under undisturbed conditions. A 24-h baseline recording was conducted at 3 months of age.
Sleep Deprivation and rMSLT
In order to evaluate the integrity of the sleep homeostatic system, animals were sleep deprived (SDep) starting at ZT0 for 4 h using gentle manipulation (e.g., light cage tapping, movement of bedding, introduction of paper towels, and/or nestlets) followed by a recovery period. EEG data were analyzed from ZT0-ZT12. SDep experiments were conducted within 4 weeks of the 24-h baseline recording.
In order to assess sleepiness, rats were evaluated using the rMSLT. 38 Beginning at ZT0, subjects went through five continuous rounds of 20-min SDep followed by a 20-min opportunity to sleep. The latencies to NREM and REM sleep during each nap opportunity were calculated as well as the total time in each sleep state across the 5 nap opportunities.
EEG and Physiological Data Analyses
Total LMA and mean T b were calculated in hourly bins. EEG recordings were analyzed for each vigilance state using Neuroscore (Data Sciences International, St. Paul, MN). All EEG scoring was performed blind to genotype. Data were divided into 10-s epochs with each epoch classified as either wakefulness (W; mixed-frequency, low-amplitude EEG and high-amplitude, variable EMG), NREM sleep (low-frequency, high-amplitude EEG and low-amplitude, steady EMG), or REM sleep (theta-dominated EEG and EMG atonia). Time spent in each vigilance state, measures of sleep/wake consolidation (bout number and duration), and REM:NREM ratios were calculated by hour, light/dark phase, and/or 24-h period. Bouts were defined as two consecutive epochs of W or NREM, or a single epoch of REM. Latency to NREM or REM sleep was defined as the time from lights on at ZT0 to the first three continuous epochs of NREM or REM, respectively. Due to the frequency bandwidth of the F40-EET transmitters used, spectral analysis of EEG data was limited to frequencies below 50 Hz and was calculated from artifact-free epochs using a Fast Fourier transform (0-50 Hz; Hanning window function). Relative power was calculated for each frequency band (delta: 0.5-4 Hz; theta: 4-9 Hz; alpha: 9-12 Hz; beta: 12-30 Hz; and gamma: 30-50 Hz) by dividing the absolute power of a given band by the absolute power across the entire frequency spectrum (0.5-50 Hz). Spectral data were normalized to WT data (average group values).
Statistical Analyses
Data were analyzed using SigmaPlot (Systat Software Inc, San Jose, CA). Unless noted otherwise, data were analyzed by twoway ANOVA (genotype x age) or two-way repeated measures ANOVA (genotype × ZT hour), and Bonferroni post hoc analyses were used. Planned comparisons using Student's t-test were made to evaluate differences between genotypes during the 24-h period, light and dark phases, and for each of the spectral frequency bands. Significances were defined as p ≤ .05.
RESULTS
Behavior
Behavioral disruptions are a hallmark feature of ASD. Since behavioral deficiencies have previously been reported in Nlgn3 KO rats, 12 we performed similar behavioral analyses to determine the interlaboratory reproducibility of the phenotypes previously described (Table 1) . KO rats were hyperactive in the open-field activity (OFA) assay as illustrated by the total distance traveled (Table 1 and Figure 2A ; p < .001), and this persisted over the duration of the test except for the first 2-min time bin ( Figure 2B ; F(9, 162) = 7.33, p < .001). KO rats showed a trend (p = .099) toward fewer social interactions across the 10-min duration of the social interaction test; these interactions were significantly lower during the first 5 minutes of the test (Table 1 , WT: 27 ± 1, KO: 21 ± 2; p = .009). While KO rats overall spent normal amounts of time investigating the social stimulus in a 3-chamber sociability test (Table 1 , p = .245), the frequency with which KO rats engaged with either the social or nonsocial stimulus was significantly greater than WT rats ( 
Diurnal Patterns of Locomotor Activity
When monitored in their home cage by telemetry, Nlgn3 KO rats exhibited activity patterns similar to WT rats with higher activity levels in the dark compared with the light phase ( Figure 2C ), although there was a trend toward a genotype × time interaction (F(23, 368) = 1.48, p = .074). Considering that rodents naturally exhibit strong diurnal rhythms, we performed a planned comparison of activity in the dark phase during which we observed a significant genotype × time interaction ( Figure 2C , F(11, 176) = 1.96, p = .035). T b in KO rats did not differ from WT across the 24-h period (F(1, 368) = 0.49, p = .494; Figure 2D ).
Sleep/Wake Time and Architecture
Despite indications of hyperactivity, Nlgn3 KO and WT rats spent equivalent times in W and had a similar number of W bouts over the 24-h period ( Figure 3A) . However, analysis of W bout duration revealed a genotype × time interaction (F(23, 368) = 1.96, p = .006), indicating that KO animals had longer W bouts particularly toward the end of the dark phase ( Figure 3A , rightmost panel). KO rats overall spent less time in NREM sleep compared with WTs ( Figure 3B ; p = .041), although NREM bout architecture (bout number and bout duration) did not significantly differ between genotypes. Despite less time in NREM sleep, KO rats spent more time in REM sleep during the light phase ( Figure 3C ; p = .008), and REM bout durations were significantly longer (p = .026). Consequently, the REM:NREM ratio was greater for KO rats during both the light period (p = .010) and over the entire 24-h period (p = .037; Figure 3D ). Despite the longer W bout duration in KO rats toward the end of the dark phase, the latencies to enter NREM or REM sleep after light onset did not differ between genotypes ( Figure 3E ; p = .842 and .541, respectively).
Spectral Composition of Vigilance States
EEG spectral power within specific low frequency ranges was significantly higher in Nlgn3 KO rats compared with WT animals across all three vigilance states ( Figure 4) . Specifically, spectral power was elevated in KO rats in the theta (4-9 Hz) band during wakefulness ( Figure 4A ; p = .036) and REM ( Figure 4C ; p = .001), whereas delta (0.5-4 Hz) power was elevated in KO rats only during NREM ( Figure 4B ; p = .041). Conversely, beta (12-30 Hz) power and gamma (30-50 Hz) power were significantly suppressed in KO rats across all vigilance states (W β: p < .001, γ: p = .033; NREM β: p = .005, γ: p = .002; REM β: p = .003, γ: p = .002). Some of these differences were dependent on the light/dark phase ( Figure S1 ). A significant elevation in delta power during NREM occurred specifically during the light phase, the period during which rats are largely inactive ( Figure S1B ; p = .024). Conversely, no change in delta power was observed during the dark phase, although theta power was significantly elevated (p = .046). Furthermore, significant suppression of alpha power was observed primarily in the light phase during periods of wakefulness ( Figure S1A ; p = .003) and NREM ( Figure S1B ; p = .026).
Sleep Homeostasis
The sleep homeostatic response was evaluated following an acute sleep deprivation (4 h). As expected, LMA and T b were elevated during the SDep period in all animals ( Figure 5) ; however, Nlgn3 KO rats had greater T b during the SDep than WT rats ( Figure 5B ; F(1, 48) = 13.57, p = .002). Furthermore, KO rats remained hyperactive during the first recovery hour following SDep and the last two hours of the dark phase (F(19, 304) = 2.69, p < .001). During recovery from SDep, repeated measures found a time × genotype interaction (F(11,176) = 2.471, p = .007) with a significant (p < .001) reduction in NREM during the first recovery hour after SD (ZT5) in KO rats ( Figure 5C ) and a significant increase in NREM in KOs at ZT12 (p = .011). Even though NREM delta power was significantly higher in KO rats primarily during the first 6 hours of the light phase during the 24-h baseline (Supplementary Figure S2 ; F(11, 160) = 4.384, p < .001), there were no differences in NREM delta power during the recovery from SDep (normalized to each animal's mean 24-h baseline NREM delta power) in KO rats compared with WT ( Figure 5D ). KO rats trended toward an increased latency to enter NREM sleep measured from ZT4, the start of the recovery period (WT: 13.6 s ± 2.4; KO: 27.6 s ± 6.1; p = .058).
The rMSLT test was used to assess sleepiness by alternating 20-min SDep periods with opportunities to sleep during their inactive period (light phase). The Nlgn3 KO rats exhibited normal latencies to enter NREM sleep (WT: 12. 
DISCUSSION
Since little is known about sleep in animal models of ASD, we evaluated sleep/wake physiology and EEG in Nlgn3 KO rats, a model with both construct and face validity for ASD. 12 We found that KO rats were hyperactive, spent less time in NREM sleep and more time in REM sleep, had greater spectral power in low frequency bands, and less spectral power in high frequency bands. These results indicate sleep abnormalities in this rodent ASD model. ASD is characterized predominantly by abnormalities in behavior, including social interactions, repetitive/restricted behaviors, and other associated symptoms including hyperactivity. Nlgn3 KO rats have previously been shown to exhibit social dysfunction, perseverative behavior, and abnormal sensorimotor gating, 12 symptoms that provide support for face validity of this strain as a model of the core and secondary features of ASD. We evaluated ASD-relevant behaviors in KO rats to determine whether the previously reported phenotypes are robust and observable across laboratories. Locomotor activity was previously found to be normal in KO rats compared with WTs
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; however, we found the KO rats to be hyperactive not only in a novel environment (the OFA box) but also in their home cage. Our measurements of activity in the home cage were algorithmically derived based on the signal strength of the implanted telemetry device and therefore may not be as sensitive as other means of activity detection (e.g., infrared beam breaks). Future studies should confirm the home cage hyperactivity phenotype using more quantitative methods for activity detection. However, it should be noted that hyperactivity was also observed using such a method (video-based motion-tracking software) in the OFA. Further support for a hyperactivity phenotype came from the three-chamber sociability test during which KO rats both exhibited increased preference for the social stimulus and also crossed into and sniffed each social/ nonsocial chamber significantly more frequently than WT rats. Play behavior during a social interaction task was previously found to be suppressed in Nlgn3 KO rats. 12 We found play behavior to be normal, although there was a trend toward a reduction in overall social behaviors (nonplay related) in KO rats. Secondary behavioral phenotypes previously observed in Nlgn3 KO rats, 12 including reduced anxiety (light-dark box), sensorimotor gating deficits (prepulse inhibition), and elevated chewing behavior, were recapitulated in the present study.
The disparity between locomotor activity and social behavior phenotypes in KO rats in this study and published data may be due to the nature in which the experiments were performed. Rats in the present study were about 2 weeks older and, since play behavior in rats is age-dependent, 39 our inability to observe differences in this behavioral domain may be due to the fact that our rats were older than the developmental age at which this behavior ceases. Our rats were also not bred in-house but ordered from a vendor; thus, it is unknown whether shipment or the housing environment at the vendor's location may have contributed to the behavioral phenotypes. While such differences cannot be definitively identified as causal, the fact that activity and social behavior phenotypes in Nlgn3 KO rats were not reproduced between labs suggests that these behaviors may be sensitive to factors such as age and/or environment.
Sleep disruptions affect most individuals with ASD; reported symptoms include difficulties falling asleep, frequent night awakenings, and reduced time asleep. 13, 40, 41 Sleep deficits can exacerbate ASD symptoms, and ASD symptom severity can predict the likelihood of sleep problems. 42 Given the high incidence of sleep abnormalities in ASD, it is perhaps not surprising that we identified sleep/wake differences between Nlgn3 KO and WT rats. However, the phenotypes observed are not completely analogous to those reported in ASD. For example, no problems were found in the propensity for KO rats to fall asleep (latency to NREM measured from light onset was normal under baseline conditions) and, contrary to the increase in REM observed in the Nlgn3 KO rats, REM sleep has been reported to be lower in people with ASD. 15 Furthermore, the latency to enter REM sleep and time spent in REM was elevated in KO rats during the rMSLT test. On the other hand, following a perturbation of sleep homeostasis by imposing a 4-h SDep, there was a trend for KO rats to take longer to enter NREM sleep.
A number of studies in humans with ASD have been conducted to determine whether EEG abnormalities exist, most of which have been performed during either evoked potential studies (in which a specific task evokes a change in brain activity) or resting state studies (in which the brain is monitored in the absence of sensory stimulation or performance of a task). Resting state studies establish a baseline for individuals which facilitates comparisons with task-dependent studies. Studies of resting state EEG (relative power) have revealed that people with ASD exhibit enhanced delta, theta, beta, and gamma and reduced alpha power. 17, 43 The Nlgn3 KO rats also demonstrated enhanced low frequency spectral power (enhanced theta during wake and REM sleep, delta during NREM sleep). However, the higher beta and gamma frequencies were significantly reduced throughout all three physiological states in Nlgn3 KO rats, contrary to the enhancement observed in ASD.
Comparison of the EEG spectral findings from the present study with those in human participants is also challenging for several reasons. Although our recordings in the Nlgn3 KO rats are collected during undisturbed home cage activity for 24 hours, this recording condition does not constitute a resting state, since the animals continue to receive sensory stimuli as they move and interact within their environment, nor does it represent a task-dependent study, since the stimuli can only be controlled to the extent of providing as uniform of an environment as possible in their home cage. A further challenge involves the age at which comparisons are made, particularly since EEG spectral composition in humans has been shown to be age-dependent. 44, 45 Despite the high prevalence of sleep problems and the availability of an increasing number of ASD animal models, few studies have endeavored to study sleep in such models to date. [19] [20] [21] [22] Male mice hemizygous for deletion of 16p11.2, a chromosomal region associated with ASD, 46 exhibit hyperactivity, increased time spent awake with consolidation of wake bouts, and decreased time spent in NREM sleep. 22 Exposure to valproic acid (VPA) in utero is associated with significantly increased risk of ASD and causes ASD-related behaviors in rodents including sleep deficits when VPA is administered during prenatal development. 19, 47 In this "environmental" model of ASD, VPA-treated rats spent more time awake with greater wake consolidation and less time in NREM sleep, thus mimicking sleep phenotypes described in human ASD populations. Furthermore, theta (4-8 Hz) power was found to be lower in VPA-treated rats across all three vigilance states, while gamma (30-80 Hz) power was significantly elevated during periods of wakefulness and REM sleep. Nlgn3 KO rats demonstrated greater consolidation of wake and less time in NREM sleep, similar to both of these models but quite distinct from the Nlgn3 R451C KI mice in which no differences in arousal state durations or sleep architecture have been reported. 26 Also in contrast to Nlgn3 R451C KI mice, Nlgn3 KO rats exhibited enhanced low frequency spectral power (enhanced theta during wake and REM sleep, delta during NREM sleep), whereas Nlgn3 R451C KI mice have reduced spectral power in the 2-8 Hz range during NREM sleep. 26 However, the data in these studies are not directly comparable, since Liu et al. report power as a percentage of spectral power in all bandwidths whereas our EEG data are normalized to that recorded from wildtype rats.
The contactin-associated protein-like 2 (CNTNAP2) gene is a member of the neurexin superfamily and associated with both cortical dysplasia focal epilepsy and ASD. [48] [49] [50] [51] [52] Knockdown of this protein in rats elicits consolidation of both wakefulness and REM sleep, whereas fragmentation of wakefulness occurs in the mouse KO model. 20 While differences were observed in the sleep architecture between rat and mouse models of CNTNAP2 deletion, reduction in alpha (9-12 Hz) power during wakefulness appeared to be consistent and conserved across both species. Interestingly, CNTNAP2 and NLGN3 both encode synaptic cell adhesion proteins, and several studies have implicated neuroligins and neurexins in regulating sleep patterns and circadian rhythms. [23] [24] [25] Knockout mice for neuroligin-1 (Nlgn1 KO) spent more time in, and exhibited higher delta power during, NREM sleep as well as had reductions in high delta/ low theta and alpha during wakefulness. 23 Mutations of the neurexin-1 and neuroligin-4 genes in Drosophila also produce sleep defects. 24, 25 Reductions in either neurexin-1 or neuroligin-4 in Drosophila result in sleep fragmentation characterized by a greater number of sleep bouts with shorter durations, whereas overexpression of neurexin-1 results in sleep consolidation. Taken together, there appear to be distinct differences in sleep/wake physiology among the mouse, rat, and insect models of ASD described to date.
The EEG measures neuronal activity and thus will likely be sensitive to alterations in synaptic activity. Proper synaptic function is also tied to sleep, and the synaptic homeostasis hypothesis proposes that sleep is critical for the restoration of synaptic homeostasis. 53 Neurodegenerative diseases such as Alzheimer's and Huntington's involve the disruption of synaptic function 54, 55 and are associated with sleep disruption. β-Amyloid pathology in the prefrontal cortex is associated with an impairment in NREM slow wave activity in humans 56 , and two mouse models of Huntington's disease reveal progressive sleep dysfunction over time with increasing time spent awake and less time in NREM. 57, 58 Neuroligins are also important for normal synaptic function and E/I balance in the CNS [5] [6] [7] [8] ; mutations or deletions of neuroligin-1, -2, or -3 are associated with impairments in excitatory and/or inhibitory synaptic transmission. 59, 60 Although Nlgn3 is widely expressed in brain, the Nlgn3 R451C mutation differentially affects synaptic transmission in the cortex and hippocampus, 60 which could be related to the differential changes in NREM and REM sleep or EEG spectral profiles in Nlgn3 KO rats. Thus, the EEG disturbances observed in the present study likely reflect abnormalities in synaptic function, but additional studies are needed to determine more specifically how synaptic dysfunction translates to an altered EEG.
The sleep disturbances observed here provide support for the use of Nlgn3 KO rats as an animal model of ASD that exhibits face validity for phenotypes beyond the core features of ASD. Since the EEG is an objective tool with quantifiable outputs that may be subject to less bias than many behavioral measures, it may thus provide a more reliable translational endpoint for researchers to utilize. However, it is important to note that the present study was performed using non-littermate controls. Even though all animals originated from the same founder parents, it is possible that, during the generations that they were bred separately, genetic alterations could have arisen that contributed to the phenotypes observed in this study. Therefore, re-assessing these results with littermate controls as well as evaluating the reproducibility of the EEG phenotype between cohorts and across labs will be important. Given the heterogeneous nature of ASD, such studies will help elucidate how common or unique EEG and sleep phenotypes are across distinct animal models of ASD.
